Login / Signup

Actinomadura graeca sp. nov.: A novel producer of the macrocyclic antibiotic zelkovamycin.

Francesco Saverio TarantiniMara BrunatiAnna TaravellaLucia CarranoFrancesco ParentiKar Wai HongPaul WilliamsKok Gan ChanStephan HeebWeng C Chan
Published in: PloS one (2021)
As part of a screening programme for antibiotic-producing bacteria, a novel Actinomadura species was discovered from a soil sample collected in Santorini, Greece. Preliminary 16S rRNA gene sequence comparisons highlighted Actinomadura macra as the most similar characterised species. However, whole-genome sequencing revealed an average nucleotide identity (ANI) value of 89% with A. macra, the highest among related species. Further phenotypic and chemotaxonomic analyses confirmed that the isolate represents a previously uncharacterised species in the genus Actinomadura, for which the name Actinomadura graeca sp. nov. is proposed (type strain 32-07T). The G+C content of A. graeca 32-07 is 72.36%. The cell wall contains DL-diaminopimelic acid, intracellular sugars are glucose, ribose and galactose, the predominant menaquinone is MK-9(H6), the major cellular lipid is phosphatidylinositol and fatty acids consist mainly of hexadecanoic acid. No mycolic acid was detected. Furthermore, A. graeca 32-07 has been confirmed as a novel producer of the non-ribosomal peptide antibiotic zelkovamycin and we report herein a provisional description of the unique biosynthetic gene cluster.
Keyphrases
  • fatty acid
  • cell wall
  • genome wide
  • genetic diversity
  • type diabetes
  • clinical trial
  • randomized controlled trial
  • dna methylation
  • adipose tissue
  • single cell
  • transcription factor
  • genome wide analysis
  • amino acid